Details for New Drug Application (NDA): 062720
✉ Email this page to a colleague
NDA 062720 describes CEPHAPIRIN SODIUM, which is a drug marketed by Abraxis Pharm and Hikma and is included in two NDAs. Additional details are available on the CEPHAPIRIN SODIUM profile page.
The generic ingredient in CEPHAPIRIN SODIUM is cephapirin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephapirin sodium profile page.
The generic ingredient in CEPHAPIRIN SODIUM is cephapirin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephapirin sodium profile page.
Summary for 062720
| Tradename: | CEPHAPIRIN SODIUM |
| Applicant: | Hikma |
| Ingredient: | cephapirin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062720
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | Jul 2, 1987 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Jul 2, 1987 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Jul 2, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
